好久没关注了,估值到了8亿美金,不错。
MannKind,吸入型重组人胰岛素Technosphere Insulin 。查看全文
chuminhua2021-10-19 11:14
10月18日,美国FDA已经就United Therapeutics和合作伙伴MannKind的Tyvaso DPI治疗肺动脉高压(PAH)和与间质性肺病(PH-ILD)相关的肺动脉高压的申请发出了完整回应函(CRL)。这一消息使MannKind的股价在周一下滑了约18%,而美联航的股票下跌了约2.5%。
该药械组合使用了United Therapeutics...查看全文
北京时间2024年01月30日05时00分,曼恩凯德生物医疗(MNKD.us)股票出现波动,股价大幅上涨5.07%。截至发稿,该股报3.52美元/股,成交量155.918万股,换手率0.58%,振幅5.97%。 最近的财报数据显示,该股实现... 网页链接
北京时间2023年12月19日02时39分,曼恩凯德生物医疗(MNKD.us)股票出现波动,股价快速下挫5.05%。截至发稿,该股报3.74美元/股,成交量125.378万股,换手率0.47%,振幅4.31%。 最近的财报数据显示,该股实现... 网页链接
$曼恩凯德(MNKD)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-10-11 AccNo: 0001193125-17-307995 Size: 366 KB 网页链接
$曼恩凯德(MNKD)$ 8-K - Current report Filed: 2017-10-11 AccNo: 0001193125-17-307989 Size: 208 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$曼恩凯德(MNKD)$ 8-K - Current report Filed: 2017-10-11 AccNo: 0001193125-17-307560 Size: 37 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$曼恩凯德(MNKD)$ 8-K - Current report Filed: 2017-10-02 AccNo: 0001193125-17-300310 Size: 72 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$曼恩凯德(MNKD)$ 8-K - Current report Filed: 2017-09-11 AccNo: 0001193125-17-281243 Size: 14 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$曼恩凯德(MNKD)$ 8-K - Current report Filed: 2017-09-06 AccNo: 0001193125-17-277862 Size: 17 KBItem 8.01: Other Events 网页链接
$曼恩凯德(MNKD)$ 内部交易: 2017-06-30,Director,PFEFFER MATTHEW J ,买入,2000普通股, $1.23
$曼恩凯德(MNKD)$ 内部交易: 2017-06-30,SVP, Investor Relations,Alinaya Rosabel Realica ,买入,2000普通股, $1.23
$曼恩凯德(MNKD)$ 内部交易: 2017-08-10,Corp VP, CMO,Urbanski Raymond W. ,卖出,296普通股, $1.15
$曼恩凯德(MNKD)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-07 AccNo: 0001193125-17-249866 Size: 5 MB 网页链接